View Item 

Show simple item record

Tumor suppressor TA p73 gene specifically responds to deregulated E2F activity in human normal fibroblasts
dc.contributor.authorOzono, Eikoen_US
dc.contributor.authorKomori, Hideyukien_US
dc.contributor.authorIwanaga, Ritsukoen_US
dc.contributor.authorTanaka, Tatsuyaen_US
dc.contributor.authorSakae, Takahiroen_US
dc.contributor.authorKitamura, Hodakaen_US
dc.contributor.authorYamaoka, Shojien_US
dc.contributor.authorOhtani, Kiyoshien_US
dc.date.accessioned2012-08-09T14:55:10Z
dc.date.available2013-10-01T17:06:31Zen_US
dc.date.issued2012-08en_US
dc.identifier.citationOzono, Eiko; Komori, Hideyuki; Iwanaga, Ritsuko; Tanaka, Tatsuya; Sakae, Takahiro; Kitamura, Hodaka; Yamaoka, Shoji; Ohtani, Kiyoshi (2012). "Tumor suppressor TA p73 gene specifically responds to deregulated E2F activity in human normal fibroblasts." Genes to Cells 17(8): 660-672. <http://hdl.handle.net/2027.42/92380>en_US
dc.identifier.issn1356-9597en_US
dc.identifier.issn1365-2443en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/92380
dc.publisherWiley Periodicals, Inc.en_US
dc.titleTumor suppressor TA p73 gene specifically responds to deregulated E2F activity in human normal fibroblastsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeneticsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid22702391en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/92380/1/gtc1617.pdf
dc.identifier.doi10.1111/j.1365-2443.2012.01617.xen_US
dc.identifier.sourceGenes to Cellsen_US
dc.identifier.citedreferenceSeelan, R.S., Irwin, M., van der Stoop, P., Qian, C., Kaelin, W.G. Jr. & Liu, W. ( 2002 ) The human p73 promoter: characterization and identification of functional E2F binding sites. Neoplasia 4, 195 – 203.en_US
dc.identifier.citedreferenceKnudsen, E.S. & Wang, J.Y. ( 1997 ) Dual mechanisms for the inhibition of E2F binding to RB by cyclin‐dependent kinase‐mediated RB phosphorylation. Mol. Cell. Biol. 17, 5771 – 5783.en_US
dc.identifier.citedreferenceKomori, H., Enomoto, M., Nakamura, M., Iwanaga, R. & Ohtani, K. ( 2005 ) Distinct E2F‐mediated transcriptional program regulates p14 ARF gene expression. EMBO J. 24, 3724 – 3736.en_US
dc.identifier.citedreferenceLau, L.M., Wolter, J.K., Lau, J.T., Cheng, L.S., Smith, K.M., Hansford, L.M., Zhang, L., Baruchel, S., Robinson, F. & Irwin, M.S. ( 2009 ) Cyclooxygenase inhibitors differentially modulate p73 isoform in neuroblastoma. Oncogene 28, 2024 – 2033.en_US
dc.identifier.citedreferenceLissy, N.A., Davis, P.K., Irwin, M., Kaelin, W.G. & Dowdy, S.F. ( 2000 ) A common E2F‐1 and p73 pathway mediates cell death induced by TCR activation. Nature 407, 642 – 645.en_US
dc.identifier.citedreferenceLowe, S.W., Cepero, E. & Evan, G. ( 2004 ) Intrinsic tumour suppression. Nature 432, 307 – 315.en_US
dc.identifier.citedreferenceMuller, H., Bracken, A.P., Vernell, R., Moroni, M.C., Christians, F., Grassilli, E., Prosperini, E., Vigo, E., Oliner, J.D. & Helin, K. ( 2001 ) E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15, 267 – 285.en_US
dc.identifier.citedreferenceOhtani, K., Tsujimoto, A., Ikeda, M. & Nakamura, M. ( 1998 ) Regulation of cell growth‐dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F. Oncogene, 17, 1777 – 1785.en_US
dc.identifier.citedreferenceOzono, E., Komori, H., Iwanaga, R., Ikeda, M.A., Iseki, S. & Ohtani, K. ( 2009 ) E2F‐like elements in p27 Kip1 promoter specifically sense deregulated E2F activity. Genes Cells 14, 89 – 99.en_US
dc.identifier.citedreferencePediconi, N., Ianari, A., Costanzo, A., Belloni, L., Gallo, R., Cimino, L., Porcellini, A., Screpanti, I., Balsano, C., Alesse, E., Gulino, A. & Levrero, M. ( 2003 ) Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat. Cell Biol. 5, 552 – 558.en_US
dc.identifier.citedreferenceRogoff, H.A., Pickering, M.T., Frame, F.M., Debatis, M.E., Sanchez, Y., Jones, S. & Kowalik, T.F. ( 2004 ) Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2. Mol. Cell. Biol. 24, 2968 – 2977.en_US
dc.identifier.citedreferenceSavelyeva, I. & Dobbelstein, M. ( 2011 ) Infection with E1B‐mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A. Oncogene 30, 86, 5 – 875.en_US
dc.identifier.citedreferenceSherr, C.J. ( 1996 ) Cancer cell cycles. Science 274, 1672 – 1677.en_US
dc.identifier.citedreferenceSherr, C.J. & McCormick, F. ( 2002 ) The RB and p53 pathways in cancer. Cancer Cell 2, 103 – 112.en_US
dc.identifier.citedreferenceStiewe, T. & Putzer, B.M. ( 2000 ) Role of the p53‐homologue p73 in E2F1‐induced apoptosis. Nat. Genet. 26, 464 – 469.en_US
dc.identifier.citedreferenceSun, Q., Ming, L., Thomas, S.M., Wang, Y., Chen, Z.G., Ferris, R.L., Grandis, J.R., Zhang, L. & Yu, J. ( 2009 ) PUMA mediates EGFR tyrosine kinase inhibitor‐induced apoptosis in head and neck cancer cells. Oncogene 28, 2348 – 2357.en_US
dc.identifier.citedreferenceTomasini, R., Tsuchihara, K., Wilhelm, M., et al. ( 2008 ) TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev. 22, 2677 – 2691.en_US
dc.identifier.citedreferenceUrist, M., Tanaka, T., Poyurovsky, M.V. & Prives, C. ( 2004 ) p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev. 18, 3041 – 3054.en_US
dc.identifier.citedreferenceYakovlev, A.G., Giovanni, S.D., Wang, G., Liu, W., Stoica, B. & Faden, A.I. ( 2004 ) BOK and NOXA are essential mediators of p53‐dependent apoptosis. J. Biol. Chem. 279, 28367 – 28374.en_US
dc.identifier.citedreferenceZhao, Y., Katzman, R.B., Delmolino, L.M., et al. ( 2007 ) The Notch regulator MAML1 interacts with p53 and functions as a coactivator. J. Biol. Chem. 282, 11969 – 11981.en_US
dc.identifier.citedreferenceDas, S., El‐Deiry, W.S. & Somasundaram, K. ( 2003 ) Regulation of the p53 homolog p73 by adenoviral oncogene E1A. J. Biol. Chem. 278, 18313 – 18320.en_US
dc.identifier.citedreferenceDeGregori, J. & Johnson, D.G. ( 2006 ) Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr. Mol. Med. 6, 739 – 748.en_US
dc.identifier.citedreferenceDimri, G.P., Itahana, K., Acosta, M. & Campisi, J. ( 2000 ) Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14 ARF tumor suppressor. Mol. Cell. Biol. 20, 273 – 285.en_US
dc.identifier.citedreferenceDyson, N. ( 1998 ) The regulation of E2F by pRB‐family proteins. Genes Dev. 12, 2245 – 2262.en_US
dc.identifier.citedreferenceFerguson, A.T., Evron, E., Umbricht, C.B., Pandita, T.K., Chan, T.A., Hermeking, H., Marks, J.R., Lambers, A.R., Futreal, P.A., Stampfer, M.R. & Sukumar, S. ( 2000 ) High frequency of hypermethylation at the 14‐3‐3 σ locus leads to gene silencing in breast cancer. Proc. Natl Acad. Sci. USA 97, 6049 – 6054.en_US
dc.identifier.citedreferenceFlores, E.R., Sengupta, S., Miller, J.B., Newman, J.J., Bronson, R., Crowley, D., Yang, A., McKeon, F. & Jacks, T. ( 2005 ) Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7, 363 – 373.en_US
dc.identifier.citedreferenceIrwin, M., Marin, M.C., Phillips, A.C., Seelan, R.S., Smith, D.I., Liu, W., Flores, E.R., Tsai, K.Y., Jacks, T., Vousden, K.H. & Kaelin, W.G. Jr. ( 2000 ) Role for the p53 homologue p73 in E2F‐1‐induced apoptosis. Nature 407, 645 – 648.en_US
dc.identifier.citedreferenceIwanaga, R., Komori, H., Ishida, S., Okamura, N., Nakayama, K., Nakayama, K.I. & Ohtani, K. ( 2006 ) Identification of novel E2F1 target genes regulated in cell cycle‐dependent and independent manners. Oncogene 25, 1786 – 1798.en_US
dc.identifier.citedreferenceIwanaga, R., Ohtani, K., Hayashi, T. & Nakamura, M. ( 2001 ) Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T‐cell leukemia virus type I. Oncogene 20, 2055 – 2067.en_US
dc.identifier.citedreferenceKaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.C., Valent, A., Minty, A., Chalon, P., Lelias, J.M., Dumont, X., Ferrara, P., McKeon, F. & Caput, D. ( 1997 ) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90, 809 – 819.en_US
dc.identifier.citedreferenceKartasheva, N., Contente, A., Lenz‐Stoppler, C., Roth, J. & Dobbelstein, M. ( 2002 ) p53 induces the expression of its antagonist p73DN, establishing an autoregulatory feedback loop. Oncogene 21, 4715 – 4727.en_US
dc.identifier.citedreferenceKern, S.E., Kinzler, K.W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C. & Vogelstein, B. ( 1991 ) Identification of p53 as a sequence‐specific DNA‐binding protein. Science 252, 1708 – 1711.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
gtc1617.pdf
Size:
1.407MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.